Christopher P. Stewart - 26 May 2021 Form 4 Insider Report for Bionano Genomics, Inc (BNGO)

Role
Chief Financial Officer
Signature
/s/ R. Erik Holmlin, Attorney-in-fact
Issuer symbol
BNGO
Transactions as of
26 May 2021
Net transactions value
+$14,000
Form type
4
Filing time
27 May 2021, 16:36:14 UTC
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Options Exercise $14,000 +25,000 +312% $0.5600 33,000 26 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Options Exercise $0 -25,000 -11% $0.000000 200,000 26 May 2021 Common Stock 25,000 $0.5600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.